The record

LegislationLegislation· Dec 2024
HR 4534

Sponsored by Brendan F. Boyle (D)

Women and Lung Cancer Research and Preventive Services Act of 2024

Would have required a federal review of lung cancer research and screening for women and underserved groups.

Tradeoff

Would have required the federal health department to study lung cancer in women and underserved groups and report to Congress within two years. The bill would have authorized no new spending, so it would not pay for new programs.

What's in it

See official bill text

No effect on direct spending or revenues; CBO has not estimated effects on discretionary spending subject to .

The bill mainly requires federal reports to Congress, so its real-world effect is limited to what produces and does, and the abstract gives no dollar figure for that work.

H.R. 4534, Women and Lung Cancer Research and Preventive Services Act of 2024 · Dec 2024

The House passed this bill by on December 16, 2024. The Senate never voted on it before the Congress ended, so the bill expired.

  1. House

    Introduced

    (Jul 11, 2023)

  2. House

    Committee on Energy and Commerce(Jul 11, 2023)

  3. House

    The Committee on Energy and Commerce voted to send it to the floor

    Reported 44 - 0(Jun 12, 2024)

    Committee report H. Rept. 118-622.

  4. House

    Passage of the bill

    Passed by (Dec 16, 2024)

    No individual votes were recorded.

  5. Senate

    Received from the House

    on Health, Education, Labor, and Pensions(Dec 17, 2024)